This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsumoto, M Articles by Yokota, T Search for Related Content PubMed PubMed Citation Articles by Matsumoto, M Articles by Yokota, T

 Previous Article  |  Next Article 

Infect Immun. 1987 November; 55(11): 2715-2720

Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.

Exploratory Research Laboratories, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.

ABSTRACT

A purified human granulocyte colony-stimulating factor (hG-CSF) was studied for its protective effect on the induction of neutropenia and enhanced susceptibility to microbial infections in mice receiving cyclophosphamide (CPA). A severe reduction in peripheral blood neutrophils was induced 4 days after injection with 200 mg of CPA per kg although the level normalized rapidly thereafter. When mice were injected subcutaneously once a day with 2.5 micrograms of hG-CSF beginning on the day after CPA injection, the reduction was prevented markedly, even 4 days later. On the other hand, in mice receiving CPA 4 days prior to infection, a weakened resistance to intraperitoneal challenge with a strain of Pseudomonas aeruginosa was induced. This weakened resistance was dose-dependently restored to normal by four daily injections with hG-CSF. A daily dose of 1.0 microgram was required for complete restoration, although hG-CSF did not directly inhibit bacterial growth in vitro. In hG-CSF-treated mice, morphologically mature neutrophils migrated rapidly into the peritoneal cavities where bacteria were inoculated, followed by a rapid elimination of bacteria from the locality as compared with controls. In addition, the same treatment with hG-CSF was able to protect significantly against systemic infections caused by Serratia marcescens, Escherichia coli, Staphylococcus aureus, and Candida albicans. These data show the possibility that prophylactic therapy with hG-CSF may augment the resistance of immunocompromised patients to infections.

This article has been cited by other articles:

• Hickman-Davis, J. M., Lindsey, J. R., Matalon, S. (2001). Cyclophosphamide Decreases Nitrotyrosine Formation and Inhibits Nitric Oxide Production by Alveolar Macrophages in Mycoplasmosis. Infect. Immun. 69: 6401-6410 [Abstract] [Full Text]  
• van Spriel, A. B., van den Herik-Oudijk, I. E., van de Winkel, J. G. J. (2001). Neutrophil Fc{{gamma}}RI as Target for Immunotherapy of Invasive Candidiasis. J. Immunol. 166: 7019-7022 [Abstract] [Full Text]  
• Onyeji, C. O., Nicolau, D. P., Nightingale, C. H., Bow, L. (2000). Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection. J Antimicrob Chemother 46: 429-436 [Abstract] [Full Text]  
• Held, T. K., Mielke, M. E.A., Chedid, M., Unger, M., Trautmann, M., Huhn, D., Cross, A. S. (1998). Granulocyte Colony-Stimulating Factor Worsens the Outcome of Experimental Klebsiella pneumoniae Pneumonia Through Direct Interaction With the Bacteria. Blood 91: 2525-2535 [Abstract] [Full Text]  
• Hartung, T., Volk, H-D., Wendel, A. (1995). G-CSF - an anti-inflammatory cytokine. Innate Immunity 2: 195-201 [Abstract]  
• Metcalf, D (1991). Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254: 529-533 [Abstract]